Our findings on the inhibition of GSK3β by PDTC are particularly interesting in the context of AD, where GSK3β not only phosphorylates tau protein [82] but also affects the expression of Aβ degrading enzymes [83]. The gene discussed is MAPT; the disease is Alzheimer disease.